Analysts/Institutional Investor Meet/Con. Call Updates Linc Limited has informed the Exchange about Transcript Linc Limited has informed the Exchange about Transcript

Read article

LINC

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Linc (LINC): Analysts/Institutional Investor Meet/Con. Call Updates

Analysts/Institutional Investor Meet/Con. Call Updates Linc Limited has informed the Exchange about Transcript Linc Limited has informed the Exchange about Transcript

Read article

LINCOLN

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Lincoln Pharmaceuticals Recommends Rs 1.80 Final Dividend for FY26

Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share for the financial year, following its board meeting on May 28, 2026. The announcement was made through NSE corporate filings.

Read article

LINCOLN

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Lincoln Pharmaceuticals Recommends Rs 1.80 Final Dividend for FY26

Lincoln Pharmaceuticals Board has recommended a final dividend of Rs 1.80 per equity share for FY26, following its May 28, 2026 meeting. The proposal awaits shareholder approval.

Read article

LINCOLN

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Lincoln Pharmaceuticals Recommends Rs 1.80 Final Dividend

Lincoln Pharmaceuticals Board recommends final dividend of Rs 1.80 per equity share following May 28, 2026 board meeting for shareholder approval.

Read article

LINCOLN

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Lincoln Pharmaceuticals Recommends Rs 1.80 Final Dividend for FY26

Lincoln Pharmaceuticals Limited's board has recommended a final dividend of Rs 1.80 per equity share following its meeting on May 28, 2026.

Read article

LINCOLN

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Lincoln Pharmaceuticals Recommends Rs 1.80 Final Dividend

Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share following its May 28, 2026 board meeting, subject to shareholder clearance.

Read article

LINCOLN

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Lincoln Pharmaceuticals Recommends Rs 1.80 Final Dividend for FY2026

Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share (18%) for FY2026, subject to approval at the upcoming Annual General Meeting.

Read article

LINCOLN

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Lincoln Pharmaceuticals Recommends ₹1.80 Final Dividend for FY26

Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share for FY26, representing an 18% return on the Rs 10 face value.

Read article

LINCOLN

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Lincoln Pharmaceuticals Proposes Rs 1.80 Final Dividend for FY26

Lincoln Pharmaceuticals has proposed a final dividend of Rs 1.80 per equity share (18%) for the financial year ended March 31, 2026, awaiting shareholder approval at the ensuing AGM.

Read article

LINCOLN

Jun 4, 2026 1 min read

Market Updates Corporate announcement